In his project, Arthur Salmon, a researcher at CentraleSupélec, aims to develop a technology that uses cold plasma to control the nucleation process of pharmaceutical molecules, helping to manage how crystals form in a solution, thereby improving the quality of the final product. The need for this technology has been validated by a market study and industry professionals.
What is the current progress of his project?
- Patent currently being drafted
- Prototype of the nucleation measurement system
Technological maturity: TRL 5
Contact us: arthur.salmon@centralesupelec.fr
